Clinical Studies

Nuvaira is committed to conducting rigorous clinical studies that help advance medical care for patients with obstructive lung diseases. Detailed information regarding all Nuvaira clinical studies can be found at

Current Clinical Studies:

AIRFLOW Clinical Study (NCT02058459)  – Enrollment Completed

Design This is a multi-center, interventional clinical trial.
Study Phase Phase 2
Study Goals The goal of the phased AIRFLOW clinical study will be:
AIRFLOW-1: to compare two energy doses to select the optimal energy and confirm safety and feasibility (recruitment closed)

AIRFLOW-2: to compare outcomes between the optimal energy dose vs. a sham control.

Patient Population Moderate to severe COPD (chronic obstructive pulmonary disease)
Countries Participating Austria, Belgium, France, Germany, Netherlands, United Kingdom.

Additional information and a list of participating clinical sites can be found at

Clinical Studies